Daxor logo thumbnail.png
Daxor Corporation to Exhibit at the Technology and Heart Failure Therapeutics Conference
February 26, 2024 08:00 ET | Daxor Corporation
Oak Ridge, TN, Feb. 26, 2024 (GLOBE NEWSWIRE) -- Daxor Corporation (NASDAQ: DXR), the global leader in blood volume measurement technology, today announces it will be exhibiting at the Technology...
54741_Image_jpeg.jpg
Caleb DesRosiers, JD, MPA Appointed to Daxor Corporation Board of Directors
January 21, 2022 08:00 ET | Daxor Corporation
Oak Ridge, TN, Jan. 21, 2022 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE: DXR), the global leader in blood volume measurement technology, announced today that it has appointed Caleb DesRosiers, JD,...
54741_Image_jpeg.jpg
Daxor Corporation to Commence Trading on The Nasdaq Capital Market On February 2, 2022
January 20, 2022 16:05 ET | Daxor Corporation
Oak Ridge, TN, Jan. 20, 2022 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE: DXR), the global leader in blood volume measurement technology, today announces that it will commence trading on The Nasdaq...
54741_Image_jpeg.jpg
Daxor Corporation to Present at the Summer Solstice - Best Ideas from the Buy Side Conference on June 2, 2021
May 28, 2021 08:30 ET | Daxor Corporation
NEW YORK, May 28, 2021 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE: DXR), the global leader in blood volume measurement technology, today announces that Michael Feldschuh, Daxor’s President and...